ReviewCureus2026
Comparative Outcomes of Immediate Versus Delayed Sequential Bilateral Cataract Surgery: A Narrative Review.
Review in Cureus, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Immediate sequential bilateral cataract surgery (ISBCS) has gained increasing international acceptance as a safe and efficient alternative to delayed sequential bilateral cataract surgery (DSBCS), yet adoption remains heterogeneous. This narrative review aims to provide an updated academic review of the comparative outcomes and safety profiles of ISBCS versus DSBCS, with emphasis on parameters most relevant to clinical decision-making and surgical policy development. A narrative review was conducted following a predefined electronic search strategy. Priority was given to national registry datasets, randomized controlled trials (RCTs), and high-volume cohort studies. Endophthalmitis rates were consistently <1/1,000 for both approaches; refractive predictability was essentially equivalent; and cystoid macular edema (CME) incidence overlapped between groups. ISBCS demonstrated shorter functional recovery and reduced healthcare resource utilization. Additionally, ISBCS was associated with up to a 50% reduction in CO
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.